Alkaloid AD Logo

Alkaloid AD

Manufactures pharmaceuticals, cosmetics, and herbal products for professionals and consumers.

ALK | MSE

Overview

Corporate Details

ISIN(s):
MKALKA101011
LEI:
Country:
North Macedonia
Address:
Blvd. Aleksandar Makedonski 12, 1000 Skopje
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Alkaloid AD is a pharmaceutical company with over eight decades of experience in the manufacturing of drugs, cosmetics, and chemical products, as well as the processing of botanical raw materials. The company's operations are structured into two primary profit centers: Pharmacy, and Chemistry, Cosmetics, and Herbal Medicine. Its product portfolio encompasses a wide range of generic drugs, with a focus on oral solid dosage forms, alongside various cosmetic and herbal products. The company also engages in pharmaceutical innovation, holding an international patent for a value-added medicine, liquid Omeprazole. Alkaloid AD serves both healthcare professionals and the general consumer market.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Alkaloid AD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Alkaloid AD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Alkaloid AD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Cabaletta Bio, Inc. Logo
Develops engineered T cell therapies for a curative reset in autoimmune diseases.
United States of America
CABA
Cadrenal Therapeutics, Inc. Logo
Developing novel anticoagulant therapies for high-risk cardiovascular patients.
United States of America
CVKD
CalciMedica, Inc. Logo
Develops CRAC channel inhibitors for critical illnesses like acute pancreatitis & AKI.
United States of America
CALC
Calidi Biotherapeutics, Inc. Logo
Develops immunotherapies using stem cells to deliver oncolytic viruses against solid tumors.
United States of America
CLDI
Calliditas Therapeutics Logo
Develops and commercializes novel treatments for rare renal and hepatic diseases like IgA nephropathy.
Sweden
CALTX
CALTH. Inc Logo
Develops AI-powered rapid diagnostic solutions for point-of-care and self-testing.
South Korea
402420
CAMBRIDGE NUTRITIONAL SCIENCES PLC Logo
Develops and manufactures diagnostic tests for food sensitivity and gut health.
United Kingdom
CNSL
Camp4 Therapeutics Corp Logo
Developing RNA-based therapies to upregulate genes for rare metabolic and CNS disorders.
United States of America
CAMP
Camurus Logo
Develops long-acting medicines for severe chronic diseases using advanced drug delivery.
Sweden
CAMX
Clinical-stage biopharma developing novel cancer drugs aiming for fewer side effects.
Japan
4575

Talk to a Data Expert

Have a question? We'll get back to you promptly.